- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02536430
Efficacy of Ketorolac Buccal Infiltration on Success Rate of Inferior Alveolar Nerve Block
Efficacy of Ketorolac Buccal Infiltration on Success Rate of Inferior Alveolar Nerve Block in Patients With Irreversible Pulpitis: A Prospective, Randomized, Double-blind Clinical Trial
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Objectives:
The aim of this study was to determine whether combining an intraoral injection of a non steroidal anti-inflammatory drug (Ketorolac), in association with conventional inferior alveolar nerve block, would improve the success rate in teeth with irreversible pulpitis.
Design: Randomized double blind clinical trial
Setting and conduct: Forty adult volunteers will randomly divide into two groups (n=20). All patients will receive standard inferior alveolar nerve block injection of 4% Articaine with 1:100000 epinephrine and supplemental buccal infiltration of 0.9 mL 4% Articaine with 1:100000 epinephrine. After five minutes when the lip numbness was achieved, one group received supplemental buccal infiltration of 30 mg/mL of Ketorolac Tromethamine and other group received buccal infiltration of normal saline. Endodontic access preparation initiated after 15 minutes of initial IANB with two negative responses to the electric pulp test. Pain during caries and dentin removal, access cavity preparation and canal length measurements has been recorded using visual analog scale (VAS). The success was considered as none or mild pain during the treatment. The data have been analyzed using Mann-U-Whitney and chi-squared tests.
Participants including major eligibility criteria: all patients with symptomatic irreversible pulpitis (Heft Parker VAS ≥54) of a mandibular molar tooth without systemic diseases; non smoking; without any medicine consumption or analgesic and sedation Intervention: Ketorolac infiltration
Main outcome measures : Pain during caries and dentin removal , access cavity preparation and canals length measurements using VAS.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 2
Kontakter og lokationer
Studiesteder
-
-
-
Tehran, Iran, Islamisk Republik
- Dental Branch, AZad UMS
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- patients with age ranged 18-65;
- without systemic diseases;
- without any medicine consumption;
- non smoking;
- non pregnant;
- non breast feeding;
- with symptomatic irreversible pulpitis (Visual Analog Scale ≥ 54) in one mandibular molar that needs root canal treatment
Exclusion Criteria:
-
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Tredobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Buccal infiltration of Ketorolac
A buccal infiltration of 30 mg/mL of Ketorolac Tromethamine was applied for the patients in case group.
|
One group received a buccal infiltration of Ketorolac Tromethamine
Andre navne:
|
Placebo komparator: buccal infiltration of Normal Saline
A buccal infiltration of Normal Saline was applied for the patients in control group.
|
buccal infiltration of Normal Saline.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Efficacy of Ketorolac infiltration on success rate of inferior alveolar nerve block
Tidsramme: One week
|
One week
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Nahid Mohammadzadeh Akhlaghi, DDS,MDS, Associate Professor
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Lægemidlers fysiologiske virkninger
- Molekylære mekanismer for farmakologisk virkning
- Agenter fra det perifere nervesystem
- Enzymhæmmere
- Analgetika
- Sensoriske systemagenter
- Anti-inflammatoriske midler, ikke-steroide
- Analgetika, ikke-narkotisk
- Anti-inflammatoriske midler
- Antirheumatiske midler
- Cyclooxygenase-hæmmere
- Ketorolac
- Ketorolac Tromethamin
Andre undersøgelses-id-numre
- AZadUMS-P/212/D
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Mislykket mekanisk induktion
-
Brno University HospitalMasaryk UniversityRekrutteringHigh Flow Oxygen ved præoxygenering under hurtig sekvensinduktion hos spædbørn og små børn (PRSIHFO)Præoxygenering | Rapid Sequence Induction (RSI)Tjekkiet
-
St George's, University of LondonUkendtLuftvejssygelighed | High Flow Oxygen i Rapid Sequence InductionDet Forenede Kongerige
-
University of MalayaUkendtEndotracheal intubation i Bed up Head Elevation Position i Rapid Sequence InductionMalaysia
Kliniske forsøg med Ketorolac Tromethamine
-
Oman Medical Speciality BoardAfsluttet
-
Queen's UniversityAfsluttet
-
Darnitsa Pharmaceutical CompanyAfsluttet
-
William Beaumont Army Medical CenterAfsluttetMuskuloskeletale smerter | Analgesi | Uønsket hændelseForenede Stater
-
Egalet LtdAfsluttetSunde frivilligeDet Forenede Kongerige
-
Université Catholique de LouvainAnticancer Fund, BelgiumAfsluttetCurative Breast Cancer Surgery | Inflammatory Positive/Negative Status | Pre Surgical Incision AdministrationBelgien
-
Beth Israel Deaconess Medical CenterSociety for Obstetric Anesthesia and PerinatologyAktiv, ikke rekrutterendePostoperativ smerte | Postpartum blødning | Blodtab, postoperativt | Analgesi, Obstetrisk | Koagulationsfejl; Efter fødslen | Ikke-steroide (NSAID) toksicitet | Ketorolac BivirkningForenede Stater
-
New Mexico Cancer Care AllianceAfsluttetLivmoderhalskræft | Æggelederkræft | Peritoneal hulrumskræftForenede Stater
-
Egalet LtdAfsluttetSunde frivilligeDet Forenede Kongerige
-
Egalet LtdAfsluttet